Techniques: CSF levels of calbindin 1 (CALB1) to predict risk and monitor progression of Niemann-Pick disease type C1 (NPC1)

Biomarkers

TECHNOLOGY: Tissue markers

CSF levels of CALB1 could help predict the risk of

Read the full 125 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE